eMedevents
  • 143,476+ Medical Conferences
  • 281 Specialties
  • 10,815 Organizers
  • 154,041 Speakers
  • 156 Countries
  • 4,643 Cities
47,825+
CME Conference Registrations Sold
Home  >  Speakers  >  Karin Hehenberger
Karin Hehenberger

Karin Hehenberger

    PhD, MD
CEO | New York, New York    United States of America
Biotechnology, Pharmacy And Medicine,...More
Biotechnology, Pharmacy,...More
Spoken at 1 event

Biography :

Dr. Hehenberger, MD, PhD is a leading medical and business expert in the biopharmaceutical industry and has more than 15 years of experience in leadership positions at JNJ, Eyetech pharmaceuticals, Coronado biosciences, and also as an investment professional at two large funds, Brummer and partners and Scandinavian Life Science Ventures.

Her dedication to diabetes is reflected by her time on the senior team at the JDRF and conducting her post-doctorate at the Joslin Diabetes Center, Harvard Medical School.

She received her MD and PhD at the Karolinska Institute in Stockholm, Sweden, where she retains a position with the Department of Endocrinology and Surgery. In 2014, she co-founded Lyfebulb, together with Mr Riccardo Braglia, CEO Helsinn and Dr Stephen Squinto, Venture partner Orbimed.

***********************
** ************
 
For speaker's contact information - Contact us

Specialties

Biotechnology, Pharmacy and Medicine, Endocrinology, Metabolism and Diabetes, Nuclear Pharmacy

Interested Topics

Biotechnology, Pharmacy, Medicine, Endocrinology, Diabetes, Metabolism, Life Science, Oncology, Cancer, Medicine, Drug Development, Immunology

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message